New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders.
Jagroop
I A
IA
Mikhailidis
D P
DP
D000251:Adenosine Triphosphatases / Q000502:physiology*; D015703:Antigens, CD / Q000502:physiology*; D001081:Apyrase / Q000378:metabolism*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013927:Thrombosis / Q000188:drug therapy*
D015703:Antigens, CD; D010975:Platelet Aggregation Inhibitors; D000251:Adenosine Triphosphatases; D001081:Apyrase; C067869:CD39 antigen